176 related articles for article (PubMed ID: 26271998)
1. The viability of mesoporous silica nanoparticles for drug delivery.
Zhang J; Rosenholm JM
Ther Deliv; 2015; 6(8):891-3. PubMed ID: 26271998
[No Abstract] [Full Text] [Related]
2. Mesoporous silica nanoparticles for intracellular controlled drug delivery.
Vivero-Escoto JL; Slowing II; Trewyn BG; Lin VS
Small; 2010 Sep; 6(18):1952-67. PubMed ID: 20690133
[TBL] [Abstract][Full Text] [Related]
3. Capped mesoporous silica nanoparticles as stimuli-responsive controlled release systems for intracellular drug/gene delivery.
Zhao Y; Vivero-Escoto JL; Slowing II; Trewyn BG; Lin VS
Expert Opin Drug Deliv; 2010 Sep; 7(9):1013-29. PubMed ID: 20716017
[TBL] [Abstract][Full Text] [Related]
4. Mussel-inspired polydopamine coated mesoporous silica nanoparticles as pH-sensitive nanocarriers for controlled release.
Zheng Q; Lin T; Wu H; Guo L; Ye P; Hao Y; Guo Q; Jiang J; Fu F; Chen G
Int J Pharm; 2014 Mar; 463(1):22-6. PubMed ID: 24393764
[TBL] [Abstract][Full Text] [Related]
5. Mesoporous-Silica-Functionalized Nanoparticles for Drug Delivery.
Giret S; Wong Chi Man M; Carcel C
Chemistry; 2015 Sep; 21(40):13850-65. PubMed ID: 26250991
[TBL] [Abstract][Full Text] [Related]
6. Biodegradation-tunable mesoporous silica nanorods for controlled drug delivery.
Park SB; Joo YH; Kim H; Ryu W; Park YI
Mater Sci Eng C Mater Biol Appl; 2015 May; 50():64-73. PubMed ID: 25746247
[TBL] [Abstract][Full Text] [Related]
7. Coiled-coil peptide motifs as thermoresponsive valves for mesoporous silica nanoparticles.
Martelli G; Zope HR; Capell MB; Kros A
Chem Commun (Camb); 2013 Nov; 49(85):9932-4. PubMed ID: 24037026
[TBL] [Abstract][Full Text] [Related]
8. Controlled drug delivery systems for cancer based on mesoporous silica nanoparticles.
Iturrioz-Rodríguez N; Correa-Duarte MA; Fanarraga ML
Int J Nanomedicine; 2019; 14():3389-3401. PubMed ID: 31190798
[TBL] [Abstract][Full Text] [Related]
9. Enzyme-responsive intracellular-controlled release using silica mesoporous nanoparticles capped with ε-poly-L-lysine.
Mondragón L; Mas N; Ferragud V; de la Torre C; Agostini A; Martínez-Máñez R; Sancenón F; Amorós P; Pérez-Payá E; Orzáez M
Chemistry; 2014 Apr; 20(18):5271-81. PubMed ID: 24700694
[TBL] [Abstract][Full Text] [Related]
10. Functionalized mesoporous silica nanoparticle-based visible light responsive controlled release delivery system.
Knežević NŽ; Trewyn BG; Lin VS
Chem Commun (Camb); 2011 Mar; 47(10):2817-9. PubMed ID: 21240408
[TBL] [Abstract][Full Text] [Related]
11. A controlled-release nanocarrier with extracellular pH value driven tumor targeting and translocation for drug delivery.
Zhao Z; Meng H; Wang N; Donovan MJ; Fu T; You M; Chen Z; Zhang X; Tan W
Angew Chem Int Ed Engl; 2013 Jul; 52(29):7487-91. PubMed ID: 23757374
[TBL] [Abstract][Full Text] [Related]
12. Controlled delivery using oligonucleotide-capped mesoporous silica nanoparticles.
Climent E; Martínez-Máñez R; Sancenón F; Marcos MD; Soto J; Maquieira A; Amorós P
Angew Chem Int Ed Engl; 2010 Sep; 49(40):7281-3. PubMed ID: 20737526
[No Abstract] [Full Text] [Related]
13. Development of insulin loaded mesoporous silica injectable particles layered by chitosan as a controlled release delivery system.
Elsayed A; Al-Remawi M; Maghrabi I; Hamaidi M; Jaber N
Int J Pharm; 2014 Jan; 461(1-2):448-58. PubMed ID: 24368103
[TBL] [Abstract][Full Text] [Related]
14. Cytochrome c end-capped mesoporous silica nanoparticles as redox-responsive drug delivery vehicles for liver tumor-targeted triplex therapy in vitro and in vivo.
Zhang B; Luo Z; Liu J; Ding X; Li J; Cai K
J Control Release; 2014 Oct; 192():192-201. PubMed ID: 25034575
[TBL] [Abstract][Full Text] [Related]
15. Drug encapsulation and release by mesoporous silica nanoparticles: the effect of surface functional groups.
Tan SY; Ang CY; Li P; Yap QM; Zhao Y
Chemistry; 2014 Sep; 20(36):11276-82. PubMed ID: 25044108
[TBL] [Abstract][Full Text] [Related]
16. [Mesoporous silica nanoparticles for cancer theranostic drug delivery].
Wang X; Teng ZG; Huang XY; Lu GM
Yao Xue Xue Bao; 2013 Jan; 48(1):8-13. PubMed ID: 23600135
[TBL] [Abstract][Full Text] [Related]
17. Triggered release in lipid bilayer-capped mesoporous silica nanoparticles containing SPION using an alternating magnetic field.
Bringas E; Köysüren Ö; Quach DV; Mahmoudi M; Aznar E; Roehling JD; Marcos MD; Martínez-Máñez R; Stroeve P
Chem Commun (Camb); 2012 Jun; 48(45):5647-9. PubMed ID: 22543447
[TBL] [Abstract][Full Text] [Related]
18. Bioresponsive controlled release from mesoporous silica nanocontainers with glucometer readout.
Hou L; Zhu C; Wu X; Chen G; Tang D
Chem Commun (Camb); 2014 Feb; 50(12):1441-3. PubMed ID: 24352686
[TBL] [Abstract][Full Text] [Related]
19. DNA-based intelligent logic controlled release systems.
Wen Y; Xu L; Li C; Du H; Chen L; Su B; Zhang Z; Zhang X; Song Y
Chem Commun (Camb); 2012 Aug; 48(67):8410-2. PubMed ID: 22801748
[TBL] [Abstract][Full Text] [Related]
20. Light-triggered reversible assemblies of azobenzene-containing amphiphilic copolymer with β-cyclodextrin-modified hollow mesoporous silica nanoparticles for controlled drug release.
Mei X; Yang S; Chen D; Li N; Li H; Xu Q; Ge J; Lu J
Chem Commun (Camb); 2012 Oct; 48(80):10010-2. PubMed ID: 22946093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
